Skip to main content

Advertisement

Log in

A case of acute aortic thrombosis after cisplatin-based chemotherapy

  • Case Report
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Cisplatin-based therapy is associated with various toxicities, including renal failure and neuropathy. However, acute arterial thrombosis is also a possible toxic effect of cisplatin, one that has been documented in a few cases worldwide. Here we present a rare case of ascending aortic thrombosis occurring 9 days after cisplatin-based chemotherapy in a 74-year-old male who was diagnosed with malignant pleural effusion suggestive of non-small cell lung cancer. The patient did not have any predisposing factor for the occurrence of an aortic thrombus before cisplatin-based chemotherapy. Thus, we suggest that the hypercoagulable state occurred secondary to cisplatin-based chemotherapy and was additive to the malignancy itself, causing aortic thrombosis. The patient was treated successfully with low-molecular-weight heparin and warfarin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Numico G, Garrone O, Dongiovanni V et al (2005) Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. Cancer 103:994–999

    Article  PubMed  Google Scholar 

  2. Starling N, Rao S, Cunningham D et al (2009) Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. J Clin Oncol 27:3786–3793

    Article  PubMed  CAS  Google Scholar 

  3. Hicks LK, Cheung MC, Ding K et al (2009) Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Cancer 115:5516–5525

    Article  PubMed  Google Scholar 

  4. Içli F, Karaoğuz H, Dinçol D et al (1993) Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer 72:597–593

    Google Scholar 

  5. Prandoni P, Piccioli A, Girolami A (1999) Cancer and venous thromboembolism: an overview. Haematologica 84:437–445

    PubMed  CAS  Google Scholar 

  6. Babu SC, Shah PM, Nitahara J (1995) Acute aortic occlusion—factors that influence outcome. J Vasc Surg 21:567–572

    Google Scholar 

  7. Barceló R, López-Vivanco G, Mañé JM et al (2000) Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine: description of four cases. Ann Oncol 11:1191–1194

    Article  PubMed  Google Scholar 

  8. Dieckmann KP, Gehrckens R (2009) Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma—a case report. BMC Cancer 9:459–462

    Google Scholar 

  9. Poirée S, Monnier-Cholley L, Tubiana JM et al (2004) Acute abdominal aortic thrombosis in cancer patients. Abdom Imaging 29:511–513

    Article  PubMed  Google Scholar 

  10. Morlese JF, Jeswani T, Beal I et al (2007) Acute ventricular and aortic thrombosis post chemotherapy. Br J Radiol 80:e75–e77

    Article  PubMed  CAS  Google Scholar 

  11. Mathews J, Goel R, Evans WK et al (1997) Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer. J Cancer Chemother Pharmacol 40:19–22

    Article  CAS  Google Scholar 

  12. Weijl NI, Rutten MF, Zwinderman AH et al (2000) Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature. J Clin Oncol 18:2169–2178

    PubMed  CAS  Google Scholar 

  13. Walsh J, Wheeler HR, Geczy CL (1992) Modulation of tissue factor on human monocytes by cisplatin and adriamycin. Br J Haematol 81:480–488

    Article  PubMed  CAS  Google Scholar 

  14. Licciarello JT, Moake JL, Rudy CK et al (1985) Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42:296–300

    Article  Google Scholar 

  15. Dvorak HF, Brown LF, Detmar M et al (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146:1029–1039

    PubMed  CAS  Google Scholar 

  16. Kuenen BC, Levi M, Meijer JC et al (2003) Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and angiogenesis inhibitor SU5416. J Clin Oncol 21:2192–2198

    Article  PubMed  CAS  Google Scholar 

  17. Lü CF, Yu HJ, Hou JX et al (2008) Increased procoagulant activity of red blood cells in the presence of cisplatin. Chin Med J 121:1775–1780

    PubMed  Google Scholar 

  18. Vogelzang NJ, Torkelson JL, Kennedy BJ (1985) Hypomagnesemia, renal dysfunction, and Raynaud’s phenomenon in patients treated with cisplatin, vinblastine, and bleomycin. Cancer 56:2765–2770

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

No author has any conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Do Yeun Kim.

About this article

Cite this article

Hahn, S.J., Oh, J.Y., Kim, J.S. et al. A case of acute aortic thrombosis after cisplatin-based chemotherapy. Int J Clin Oncol 16, 732–736 (2011). https://doi.org/10.1007/s10147-011-0205-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-011-0205-7

Keywords

Navigation